Loading the records…
Loading the records…
The PATCH Act, introduced May 21, 2026, would ban medical debt from consumer credit reports and prohibit creditors from using medical debt in lending decisions. This largely codifies existing CFPB rules and industry practices — major banks have already removed most medical debt from underwriting. No material financial impact on JPMorgan ($JPM), Bank of America ($BAC), Citigroup ($C), or Wells Fargo ($WFC) given it affects <0.1% of revenue.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
US banking stocks are unaffected by this bill. The legislation is procedurally weak — single sponsor, no companion bill, referred to committee with no further action. Market pricing of bank stocks already reflects the existing CFPB rule. No positioning required. For retail investors, this is a non-event. Focus on other congressional actions with real spending or regulatory teeth.
This bill, S. 4622, the PATCH Act, was introduced by Sen. Kennedy (R-LA) on May 21, 2026, and referred to the Senate Banking Committee. It is in an early stage with no markup or vote scheduled. The bill amends the Fair Credit Reporting Act to exclude all 'medical debt' from consumer reports and requires the CFPB to revise Regulation B (Equal Credit Opportunity Act) to bar creditors from using medical debt in credit decisions. There is no authorized funding; this is a regulatory mandate on private companies. The CFPB already finalized a rule in January 2023 removing medical debt under $500 from credit reports, and in January 2025 proposed a broader rule targeting all medical debt. Most major lenders (JPM, BAC, C, WFC) already apply internal policies minimizing medical debt weighting. The incremental impact of this bill is therefore marginal — it would codify existing practices, potentially adding enforcement risk for noncompliance but not changing day-to-day operations. The only potential winners are consumers with outstanding medical debt, who may see slight credit score improvements. No publicly traded company stands to gain or lose significant revenue. Collections agencies and credit bureaus (Equifax, Experian, TransUnion — private or foreign-listed) could see negligible data processing changes. Among major US banks, the affected revenue is below 0.1% of total, making this a neutral event for investors. Timeline: remains in committee; companion bill in House not yet introduced. Passage probability before the 2026 midterms is low given early stage and lack of bipartisan co-sponsors.
Matched on shared policy language across AI analyses, with ticker & timing weight
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
To amend title 11, United States Code, to provide bankruptcy protections for medically distressed debtors, and for other purposes.
GUIDANCE Act of 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; File Disclosure".
Executive orders & memoranda affecting the same sectors or companies
This executive order directs the Federal Housing Finance Agency to create pilot programs for automatic cancellation of mortgage insurance when borrowers have sufficient equity, and to expand a title insurance pilot to reduce costs for refinancing. It establishes a task force to promote manufactured housing by standardizing permits and reducing regulatory barriers. It also orders the Departments of Agriculture and Veterans Affairs to reduce interest rates on direct home loans.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This memorandum establishes a committee to investigate Federal Reserve Governor Lisa Cook for alleged false statements related to mortgage instruments, with a hearing scheduled and a recommendation on removal. It directs the Attorney General, Counsel to the President, and others to participate, and sets a timeline for findings.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →